ID

25103

Beschreibung

A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00823771

Link

https://clinicaltrials.gov/show/NCT00823771

Stichworte

  1. 25.08.17 25.08.17 -
Hochgeladen am

25. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00823771

Eligibility Prostate Cancer NCT00823771

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
men with a tumour t1-3 stage prostate cancer and have had radical radiotherapy with curative intent
Beschreibung

Prostate carcinoma TNM clinical staging | Therapeutic radiology procedure Radical Curative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0439807
UMLS CUI [2,3]
C1276305
are between six and twelve months post-treatment completion
Beschreibung

Treatment completion Status post

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0580352
UMLS CUI [1,2]
C0231290
have completed all treatment for prostate cancer (including hormonal deprivation therapy)
Beschreibung

Treatment completed Prostate carcinoma | Antiandrogen therapy completed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0580352
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C0279492
UMLS CUI [2,2]
C0205197
have no evidence of metastatic disease
Beschreibung

Neoplasm Metastasis Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0332197
ecog performance status of between 0-1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
remains willing to comply with study requirements
Beschreibung

Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
has maintained contact with an individual general practitioner
Beschreibung

Contact with General Practitioner

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332158
UMLS CUI [1,2]
C0017319
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
persistent complications resulting from treatment defined as a minimum grade 3 treatment toxicity
Beschreibung

Complications persistent Due to Therapeutic procedure | Toxicity CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0205322
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0087111
UMLS CUI [2,1]
C0600688
UMLS CUI [2,2]
C1516728
unable to complete self-administered questionnaires
Beschreibung

Questionnaire Administration Completion Unable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1882515
UMLS CUI [1,2]
C0205197
UMLS CUI [1,3]
C1299582
are currently enrolled in a study that requires specialist follow-up
Beschreibung

Study Subject Participation Status Requirement Specialist follow-up

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C2348234
UMLS CUI [1,4]
C1522577
life expectancy of less than 6 months
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
surgery to remove the prostate
Beschreibung

Prostatectomy

Datentyp

boolean

Alias
UMLS CUI [1]
C0033573
evidence of biochemical failure
Beschreibung

Failure Biochemical

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0231174
UMLS CUI [1,2]
C0205474

Ähnliche Modelle

Eligibility Prostate Cancer NCT00823771

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma TNM clinical staging | Therapeutic radiology procedure Radical Curative
Item
men with a tumour t1-3 stage prostate cancer and have had radical radiotherapy with curative intent
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0439807 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
Treatment completion Status post
Item
are between six and twelve months post-treatment completion
boolean
C0580352 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
Treatment completed Prostate carcinoma | Antiandrogen therapy completed
Item
have completed all treatment for prostate cancer (including hormonal deprivation therapy)
boolean
C0580352 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0279492 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Neoplasm Metastasis Absent
Item
have no evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status of between 0-1
boolean
C1520224 (UMLS CUI [1])
Protocol Compliance
Item
remains willing to comply with study requirements
boolean
C0525058 (UMLS CUI [1])
Contact with General Practitioner
Item
has maintained contact with an individual general practitioner
boolean
C0332158 (UMLS CUI [1,1])
C0017319 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Complications persistent Due to Therapeutic procedure | Toxicity CTCAE Grades
Item
persistent complications resulting from treatment defined as a minimum grade 3 treatment toxicity
boolean
C0009566 (UMLS CUI [1,1])
C0205322 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0600688 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
Questionnaire Administration Completion Unable
Item
unable to complete self-administered questionnaires
boolean
C1882515 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Study Subject Participation Status Requirement Specialist follow-up
Item
are currently enrolled in a study that requires specialist follow-up
boolean
C2348568 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C2348234 (UMLS CUI [1,3])
C1522577 (UMLS CUI [1,4])
Life Expectancy
Item
life expectancy of less than 6 months
boolean
C0023671 (UMLS CUI [1])
Prostatectomy
Item
surgery to remove the prostate
boolean
C0033573 (UMLS CUI [1])
Failure Biochemical
Item
evidence of biochemical failure
boolean
C0231174 (UMLS CUI [1,1])
C0205474 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video